Scheduled Maintenance Notice | Our website will be undergoing maintenance on Saturday, September 6th, from 9:00 AM ET through 11:00 AM ET. During this time, the site will be temporarily unavailable. We apologize for any inconvenience and appreciate your patience.

Compliance

Auburn is committed to ensuring that all of our products are purchased though the legitimate pharmaceutical supply chain and meet all of the requirements of the Drug Supply Chain Security Act (DSCSA).

We will continue to be in full compliance of the DSCSA saleable returns requirement that begins on November 27, 2020.

Drug Supply Chain Security

Auburn is accredited by NABP
Find a NABP-Accredited Facility

NABP logo

Healthcare Distribution Alliance

The HDA, Healthcare Distribution Alliance, is a national organization representing primary pharmaceutical distributors.

HDA logo

DSCSA Compliance

At Auburn Pharmaceutical, we remain steadfast in our commitment to safeguarding the integrity of the pharmaceutical supply chain. As part of that commitment, we are now actively transmitting EPCIS data to all of our downstream trading partners, ensuring greater transparency, reliability, and compliance across the industry.

To further support this transition and provide an added layer of assurance, the FDA has granted Auburn a temporary exemption from certain enhanced DSCSA requirements under Section 582(g)(1) of the Federal Food, Drug, and Cosmetic Act. This exemption is effective from August 27, 2025, through May 27, 2026, and extends to all downstream partners.

For questions, please contact us at (800) 222-5609 or via email at DSCSA@auburnpharm.com.

Licenses

We are licensed across the continental United States and operate NABP-Accredited facilities in Salt Lake City, Utah and Rochester Hills, Michigan. We follow the Healthcare Distribution Alliance (HDA) guidelines for best practices and quality control.